🤝  Bristol Myers Squibb  is set to acquire  2seventy bio  in an all-cash transaction valued at approximately $286 million. After...

Bladder cancer is the most common malignancy of the urinary tract. As of 2022, Bladder Cancer had an incidence of 614,298 patients...

PD-(L)1 axis inhibits CAR-T cell activation, proliferation, survival, and functionality. Thus, CAR-T mediated direct targeting of the...